Q3 earnings call Friday November 1 | IMGN Message Board Posts

ImmunoGen, Inc.

  IMGN website

IMGN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  49990 of 50055  at  10/19/2019 1:46:16 PM  by

GaryM


 In response to msg 49989 by  Biotechbeagle
view thread

Re: Q3 earnings call Friday November 1

I believe that language is normal for their releases. I would hope that by then they can discuss presentations of their and partners products at the technical conferences coming up by the end of the year.

Right now I believe that one or more partnerships could be the thing that moves the stock the most. I still believe that IMGN853 in a ROW partnership should bring in substantial funds, but clearly not what it would have brought if we were still expecting an approval next year. At this point little is unknown about what's needed to gain approval, the major unknown is what it will do in other cancers with high platinum resistant patients. A BP partner might be willing to fund additional trials in other cancers, but if not, it will almost certainly happen post approval for ovarian cancer.

Gary



     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 260
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...